When the plasma is released at the end of quarantine storage, the deep-frozen single plasma units are thawed under controlled conditions and transferred from the plasma bag to the glass bottle under sterile conditions using a patented closed system. During this process, an integrated filter eliminates any blood cells or cell debris still present in the plasma. The whole process is computer-controlled and monitored.
In preparation for freeze-drying, the bottles of plasma are then sealed and spin-frozen at a temperature of less than -30°C. Subsequently the product is gently dehydrated by subliming it under vacuum, while gradually raising the temperature from -45°C to + 5°C over several days. Labelling and packaging complete the production process.
In accordance with the EU Directive on Good Manufacturing Practice all critical manufacturing steps take place in clean rooms and are extensively controlled and documented.
Read the package leaflet and ask your doctor or pharmacist about potential risks and side effects.